🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A randomized, observer-blind non-inferiority trial to evaluate alternative ...
Status
Unknown
Location
Ed Clarke
Start Date
2019-09-14
Trial ID
NCT03832049
This double-blinded clinical trial randomly assigns participants with refra...
Status
Recruiting
Location
University of Utah Midvalley Health Center
Start Date
2024-03-25
Trial ID
NCT05625633
Treatments Being Tested
The primary objective of this study is to determine the magnitude and bread...
Status
Recruiting
Location
University Medical Center New Orleans
Start Date
2022-11-30
Trial ID
NCT05266898
Treatments Being Tested
The purposes of this phase 3, double-blind, placebo-controlled clinical stu...
Status
Completed
Location
Umeyama Clinic ( Site 6406)
Start Date
2020-11-30
Trial ID
NCT04635423
This is a single-center, Phase II interventional study evaluating secondary...
Status
Recruiting
Location
Centre Oscar Lambret
Start Date
2025-01-13
Trial ID
NCT06658405
Treatments Being Tested
This randomized phase III trial studies how well human papillomavirus (HPV)...
Status
Completed
Location
Moi University School of Medicine
Start Date
2019-07-31
Trial ID
NCT03284866
Treatments Being Tested
This study is an open-label nonrandomized exploratory proof of concept and ...
Status
Active Not Recruiting
Location
Boston Medical Center
Start Date
2022-09-26
Trial ID
NCT05329961
Treatments Being Tested
Add-Vacc is an unblinded cluster-randomised trial (CRT) with two arms: (i) ...
Status
Active Not Recruiting
Location
Mwanza Intervention Trials Unit
Start Date
2022-08-01
Trial ID
NCT04953130
Treatments Being Tested
The study will evaluate the immunogenicity and safety of 4-valent and 9-val...
Status
Completed
Location
Yangchun Center For Disease Prevention And Control
Start Date
2020-05-28
Trial ID
NCT04425291
Treatments Being Tested
This is a 96-month safety and immunogenicity study conducted in boys and gi...
Status
Active Not Recruiting
Location
Kaiser Permanente Daly City ( Site 0044)
Start Date
2021-03-15
Trial ID
NCT04708041
Treatments Being Tested